Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avid Bioservices Completes Lab Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Avid Bioservices Completes Lab Expansion

Strengthens process development capabilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Avid Bioservices, a biologics contract development and manufacturing organization (CDMO), has completed the expansion of the company’s process development capabilities and laboratory space within its CDMO campus in Orange County, CA. To celebrate the launch of its newly expanded facilities, Avid is hosting an open house and laboratory tour for existing and prospective clients.
 
The completed expansion project further strengthens the company’s capabilities in the areas of R&D support, process development, process characterization and validation, and pilot scale production for a broad range of biotechnology products.
 
According to the company, the new suites accelerate its ability to develop and deliver cost-effective, robust, scalable and compliant processes and to drive efficient and rapid “on-boarding” of new customer programs progressing to manufacturing. Specific enhancements include a four-fold expansion of the company’s process development laboratory footprint and the addition of 24 advanced benchtop process development bioreactors, ranging from 3 liter to 15 liter capacity in single-use and glass.
 
“We are very excited to bring these state-of-the-art upstream and downstream process development laboratories online,” said Rick Hancock, interim president and chief executive officer, Avid Bioservices. “This represents another major milestone in positioning Avid at the top tier of biologics CDMOs and supports the ongoing expansion of our customer base, while providing additional capabilities for our current clients.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics